Surrozen (SRZN) Stock Rating Buy with $44 Target by H.C. Wainwright
Published on · Source: investing.com

AI Summary
Summarized by AI from the source belowH.C. Wainwright has reaffirmed its 'buy' rating on Surrozen (SRZN) and set a price target of $44 per share. This endorsement may influence investor sentiment, as analysts typically provide insights into a company's growth potential. The confirmation of a buy rating suggests confidence in Surrozen's future performance. This is particularly relevant for investors looking for growth opportunities in the biotech sector.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Related News

Earnings
Abeona Therapeutics stock Buy rating maintained by H.C. Wainwright
Sep 25

Earnings
Ultragenyx Stock Rating Reiterated by H.C. Wainwright on FDA Approval
Sep 25

Earnings
Surrozen Stock Target Raised on Wnt Pathway Validation Insight
Sep 25

Tech
Kyverna Stock Rating Reiterated by H.C. Wainwright on Durability Data
Sep 25